Citi Adds Nektar Therapeutics (NKTR) to 30-Day Upside Catalyst Watch List
Tweet Send to a Friend
Citi analyst Samantha Semenkow reiterated a Buy rating and $123.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
